Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 825-833

  Bedaiwy, Mohamed A ^a   Mousa, Noha A ^a   Esfandiari, Navid ^a   Forman, Rachel ^a   Casper, Robert F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DYNAMICS; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HORMONE DETERMINATION; HUMAN; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; STRATIFICATION;

EID: 33947533077     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1673     Document Type: Article

References (25)

1. Casper RF, Mitwally MF 2006 Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 91:760-771
2. Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RF 2006 Cost effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Hum Reprod 21:2838-2844
3. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF 2006 Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85:1761-1765
4. Weil S, Vendola K, Zhou J, Bondy CA 1999 Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84:2951-2956
5. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, Pellicer A 2005 The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84:82-87
6. Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M 2005 Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 83:110-115
7. Gonen Y, Casper RF 1990 Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5:670-674
8. Creus M, Ordi J, Fabregues F, Casamitjana R, Carmona F, Cardesa A, Vanrell JA, Balasch J 2003 The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod 18:683-693
9. Bayar U, Tanriverdi HA, Barut A, Ayoglu F, Ozcan O, Kaya E 2006 Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril 85:1045-1048
10. Mitwally MF, Casper RF 2004 Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 11:406-415
11. Simon C, Cano F, Valbuena D, Remohi J, Pellicer A 1995 Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 10:2432-2437
12. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452-458
13. Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T 2006 A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 85:161-164
14. Sioufi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM, Godbillon J, Czendlik C, Howald H, Pfister C, Vreeland F 1997 Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos 18:779-789
15. Sioufi A, Sandrenan N, Godbillon J, Trunet P, Czendlik C, Howald H, Pfister C, Ezzet F 1997 Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration. Biopharm Drug Dispos 18:489-497
16. Kurl RN, Morris ID 1978 Differential depletion of cytoplasmic high affinity oestrogen receptors after the in vivo administration of the antioestrogens, clomiphene, MER-25 and tamoxifen. Br J Pharmacol 62:487-493
17. Fisher SA, Reid RL, Van Vugt DA, Casper RF 2002 A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 78:280-285
18. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z 2005 Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347-4353
19. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H 2006 Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885-3890
20. Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R, Mannaerts B 2006 Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicenter trial. Hum Reprod 21:632-639
21. Loumaye E 1990 The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 5:357-376
22. Nirmala PB, Thampan RV 1995 Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 213:24-31
23. Rosenfeld CR, Roy T, Cox BE 2002 Mechanisms modulating estrogen-induced uterine vasodilation. Vascul Pharmacol 38:115-125
24. Healey S, Tan SL, Tulandi T, Biljan MM 2003 Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 80:1325-1329
25. Mitwally MF, Biljan MM, Casper RF 2005 Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 192:381-386